Clinical Trial Results
Showing:
All studies
[change]
Condition: Cancer
Location: Scottsdale, Arizona
25 trials found
New Search
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
RECRUITING
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
RECRUITING
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RECRUITING
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
RECRUITING
Role of Gut Microbiome in Cancer Therapy
RECRUITING
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
RECRUITING
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
RECRUITING
Cancer Genetic Testing in Ethnic Populations
RECRUITING
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
RECRUITING
Pancreatic Cancer Early Detection Consortium
RECRUITING
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
RECRUITING
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RECRUITING
Dabrafenib and/or Trametinib Rollover Study
RECRUITING
The PREDICT Registry:
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RECRUITING
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RECRUITING
Caris Biorepository Research Protocol
RECRUITING
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RECRUITING
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
RECRUITING
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RECRUITING
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
RECRUITING
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RECRUITING
AOH1996 for the Treatment of Refractory Solid Tumors
RECRUITING